Healthcare provider profile · identity verified

Robert K Aichele, DO

Family Practice · WILLOW STREET, PA · NPI 1366485583

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	527	151
Lisinopril	Lisinopril	448	118
Levothyroxine Sodium	Levothyroxine Sodium	331	90
Metformin Hcl	Metformin Hcl	325	81
Amlodipine Besylate	Amlodipine Besylate	300	80
Simvastatin	Simvastatin	298	75
Omeprazole	Omeprazole	293	83
Losartan Potassium	Losartan Potassium	268	70
Metoprolol Succinate	Metoprolol Succinate	262	74
Gabapentin	Gabapentin	250	56
Hydrochlorothiazide	Hydrochlorothiazide	227	63
Tamsulosin Hcl	Tamsulosin Hcl	227	63
Oxycodone Hcl	Oxycodone Hcl	205	33
Sertraline Hcl	Sertraline Hcl	193	49
Alprazolam	Alprazolam	192	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	164	28
Lorazepam	Lorazepam	157	38
Furosemide	Furosemide	148	43
Eliquis	Apixaban	144	30
Pantoprazole Sodium	Pantoprazole Sodium	139	37
Rosuvastatin Calcium	Rosuvastatin Calcium	139	44
Tramadol Hcl	Tramadol Hcl	119	34
Allopurinol	Allopurinol	118	28
Glimepiride	Glimepiride	118	31
Albuterol Sulfate Hfa	Albuterol Sulfate	116	47
Escitalopram Oxalate	Escitalopram Oxalate	115	32
Januvia	Sitagliptin Phosphate	104	22
Jardiance	Empagliflozin	104	16
Zolpidem Tartrate	Zolpidem Tartrate	96	21
Diclofenac Sodium	Diclofenac Sodium	91	30
Pravastatin Sodium	Pravastatin Sodium	91	28
Metoprolol Tartrate	Metoprolol Tartrate	86	23
Prednisone	Prednisone	86	63
Metformin Hcl Er	Metformin Hcl	85	22
Trazodone Hcl	Trazodone Hcl	82	24
Carvedilol	Carvedilol	78	26
Duloxetine Hcl	Duloxetine Hcl	78	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	77	11
Clonazepam	Clonazepam	76	21
Morphine Sulfate Er	Morphine Sulfate	74	suppressed
Famotidine	Famotidine	73	23
Trulicity	Dulaglutide	73	15
Montelukast Sodium	Montelukast Sodium	72	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	71	27
Citalopram Hbr	Citalopram Hydrobromide	68	16
Dicyclomine Hcl	Dicyclomine Hcl	68	17
Finasteride	Finasteride	68	19
Clopidogrel	Clopidogrel Bisulfate	67	20
Fluoxetine Hcl	Fluoxetine Hcl	65	15
Warfarin Sodium	Warfarin Sodium	65	13
Spironolactone	Spironolactone	60	17
Synthroid	Levothyroxine Sodium	60	14
Alendronate Sodium	Alendronate Sodium	57	13
Chlorthalidone	Chlorthalidone	56	13
Ezetimibe	Ezetimibe	56	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	54	44
Oxycontin	Oxycodone Hcl	53	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	50	50
Fluticasone Propionate	Fluticasone Propionate	50	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	suppressed
Potassium Chloride	Potassium Chloride	49	17
Pregabalin	Pregabalin	48	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	47	11
Benazepril Hcl	Benazepril Hcl	47	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	47	13
Meloxicam	Meloxicam	45	15
Celecoxib	Celecoxib	44	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Atenolol	Atenolol	38	13
Doxycycline Hyclate	Doxycycline Hyclate	37	14
Fentanyl	Fentanyl	37	suppressed
Glipizide Er	Glipizide	37	11
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Ozempic	Semaglutide	36	suppressed
Baclofen	Baclofen	34	suppressed
Glipizide	Glipizide	33	11
Valsartan	Valsartan	33	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Mirtazapine	Mirtazapine	30	11
Triamcinolone Acetonide	Triamcinolone Acetonide	30	20
Meclizine Hcl	Meclizine Hcl	29	14
Lovastatin	Lovastatin	28	suppressed
Tradjenta	Linagliptin	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Naproxen	Naproxen	26	suppressed
Promethazine Hcl	Promethazine Hcl	25	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Ramipril	Ramipril	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Azithromycin	Azithromycin	20	17
Nitrofurantoin	Nitrofurantoin Macrocrystal	19	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Nystatin	Nystatin	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Linzess	Linaclotide	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	11
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Azelastine Hcl	Azelastine Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	12
Primidone	Primidone	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Cephalexin	Cephalexin	14	11
Clonidine Hcl	Clonidine Hcl	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Invokana	Canagliflozin	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Torsemide	Torsemide	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Multaq	Dronedarone Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Victoza 3-Pak	Liraglutide	13	suppressed
Acebutolol Hcl	Acebutolol Hcl	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Donepezil Hcl	Donepezil Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error